Exact Sciences under modest pressure on new report from long-term bear Citron, shares down 3%

|By:, SA News Editor

Exact Sciences (EXAS -2.7%) is down on more than 40% higher volume on the heels of a new report by persistent bear Citron Research.

Citron cites the competitive threat from liquid biopsies and slowing test volume growth for Cologuard.

Previously: Exact Sciences under pressure on potential CRC blood screening test; shares down 9% (Jan. 17)

Previously: Exact Sciences to expand capacity to 4.5M Cologuard tests/year (Nov. 8, 2017)

Subscribe for full text news in your inbox